Please login to the form below

Not currently logged in
Email:
Password:

omarigliptin

This page shows the latest omarigliptin news and features for those working in and with pharma, biotech and healthcare.

Merck drops once-weekly diabetes drug in US and EU

Merck drops once-weekly diabetes drug in US and EU

Merck &Co will no longer file for approval of once-weekly diabetes drug omarigliptin in the US or Europe, even though it is already on the market in Japan. ... As recently as last September, Merck was suggesting it would file for approval of omarigliptin

Latest news

More from news
Approximately 2 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics